Literature DB >> 10077528

Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.

J E Watson1, H Gabra, K J Taylor, G J Rabiasz, H Morrison, P Perry, J F Smyth, D J Porteous.   

Abstract

We have performed representational difference analysis (RDA) on DNA from tumor cells and normal fibroblasts isolated from the ascites of a patient with ovarian cancer. Five of six products of the RDA were homozygously deleted from the tumor DNA. One of these products has been characterized and identifies a homozygous deletion of approximately 6.9 Mb at chromosome 9p21 in the original ovarian tumor material. This deletion encompasses CDKN2A (p16), CDKN2B (p15), and IFN-alpha. PCR analysis of other tumor cell lines using the novel STS based on the RDA product has shown it to lie between IFN-alpha and p16, and to identify the distal extent of a homozygous deletion in another ovarian cancer cell line. These data provide further evidence for a tumor suppressor locus distinct from, but mapping close to, p16 on 9p21. Cytogenetic analysis using comparative genomic hybridization (CGH) performed on the same primary tumor confirmed a loss of material from chromosome 9p. However, the CGH technique had neither the resolution nor the sensitivity to define a subregion of homozygous loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077528

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  4 in total

Review 1.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.

Authors:  Benjamin G Bitler; Jasmine P Nicodemus; Hua Li; Qi Cai; Hong Wu; Xiang Hua; Tianyu Li; Michael J Birrer; Andrew K Godwin; Paul Cairns; Rugang Zhang
Journal:  Cancer Res       Date:  2011-08-04       Impact factor: 12.701

3.  Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.

Authors:  Katherine M Aird; Hua Li; Frances Xin; Panagiotis A Konstantinopoulos; Rugang Zhang
Journal:  Cell Cycle       Date:  2013-10-29       Impact factor: 4.534

4.  Primary culture and mRNA analysis of human ovarian cells.

Authors:  Lesley D. Dunfield; Trevor G. Shepherd; Mark W. Nachtigal
Journal:  Biol Proced Online       Date:  2002-10-28       Impact factor: 3.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.